Liquid Biopsies in Pediatric Solid Tumors
Recruiting
- Conditions
- Pediatric Solid Tumor, Unspecified, Protocol Specific
- Registration Number
- NCT05068583
- Lead Sponsor
- Children's Hospital Los Angeles
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 320
Inclusion Criteria
Inclusion Criteria:<br><br> - Newly diagnosed, relapsed, or refractory histologically confirmed high grade bone or<br> soft tissue sarcoma or malignant renal, thyroid, germ cell, or hepatic tumors, OR<br><br> - Healthy individual with no history of cancer or chronic medical problems and < 21<br> years of age<br><br>Exclusion Criteria:<br><br> - CNS Malignancies<br><br> - Individuals < 6 months of age
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To detect circulating tumor DNA (ctDNA) in serial blood samples from patients with pediatric non-CNS solid tumors using low pass whole genome sequencing.
- Secondary Outcome Measures
Name Time Method